Clinical Trials
3 trialsNCT06754761 2025-01-01
Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib
AstraZeneca
Phase 1 Not yet recruiting
NCT02630199 2022-06-15
Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory Cancer
Samsung Medical Center
Phase 1 Completed
NCT03669601 2021-06-04
ATRiUM
Cambridge University Hospitals NHS Foundation Trust
Phase 1 Unknown